\-\ Texto\\:\\ \ \(0\)\
\-\ vitals\\ normal\\ except\\ for\\ po2\\ 73\\%\ \(0\)\
\-\ hr\\-\\ regular\\,\\ no\\ murmurs\ \(0\)\
\-\ lungs\\-\\ clear\\ bilaterally\\,\\ no\\ bruits\\,\\ no\\ wheezes\ \(0\)\
\-\ skin\\-\\ several\\ small\\ spider\\ like\\ lesions\\ on\\ upper\\ back\\,\\ perioral\\ cyanosis\\,\\ clubbing\\ of\\ fingers\\.\ \(0\)\
\-\ labs\\:\\ hemoglobin\\/hematocrit\\=\\ 17\\.8\\/53\ \(0\)\
\-\ the\\ patient\\ was\\ admitted\\ for\\ observation\\ and\\ further\\ workup\\ of\\ possible\\ genetic\\ disease\\.\\ a\\ ct\\ of\\ the\\ entire\\ abdomen\\ was\\ obtained\\ which\\ did\\ not\\ show\\ any\\ other\\ areas\\ of\\ avm\\'s\\.\\ \\ he\\ also\\ had\\ a\\ ct\\ scan\\ of\\ the\\ head\\ which\\ showed\\ a\\ small\\ enhancing\\ lesion\\ possibly\\ consistent\\ with\\ an\\ intracranial\\ avm\\.\\ \\ genetics\\ was\\ consulted\\ and\\ it\\ was\\ determined\\ that\\ the\\ pulmonary\\ avm\\'s\\ were\\ likely\\ congenital\\ and\\ associated\\ with\\ hereditary\\ hemorrhagic\\ telangiectasia\\.\\ \\ he\\ was\\ evaluated\\ by\\ interventional\\ radiology\\ and\\ plans\\ were\\ made\\ for\\ embolization\\ of\\ the\\ avm\\'s\\ in\\ the\\ near\\ future\\.\ \(0\)\
\-\ cxr\\ shows\\ opacities\\ present\\ in\\ both\\ lungs\\.\\ several\\ abnormal\\ vasculature\\ collections\\ with\\ dilated\\ arterial\\ supply\\ and\\ venous\\ drainage\\.\\ \\ one\\ in\\ the\\ right\\ lung\\ and\\ three\\ in\\ the\\ left\\ lung\\ of\\ varying\\ sizes\\.\ \(0\)\
\-\ pulmonary\\ arteriovenous\\ malformation\\-\\ hereditary\\ hemorrhagic\\ telangiectasias\ \(0\)\
\-\ metastatic\\ disease\ \(243\)\
\-\ pulmonary\\ arteriovenous\\ malformations\ \(2\)\
\-\ granulomatous\\ disease\ \(29\)\
\-\ pulmonary\\ nodules\ \(54\)\
\-\ 13\\ year\\ old\\ male\\ presenting\\ for\\ routine\\ visit\\ noted\\ to\\ have\\ oxygen\\ saturation\\ of\\ 73\\%\\.\\ the\\ mother\\ states\\ his\\ fingernails\\ have\\ always\\ been\\ bluish\\.\\ \\ he\\ has\\ had\\ nosebleeds\\ 2\\-3\\ times\\ a\\ month\\ since\\ age\\ 2\\.\\ \\ denies\\ difficulty\\ breathing\\ or\\ other\\ respiratory\\ symptoms\\.\ \(0\)\
\-\ fhx\\:\\ father\\ noted\\ to\\ have\\ several\\ telangiectasias\\ on\\ back\\ and\\ on\\ oral\\ mucosa\\.\ \(0\)\
\-\ hereditary\\ hemorrhagic\\ telangiectasia\\ also\\ known\\ as\\ rendu\\-osler\\-weber\\ syndome\\ is\\ an\\ autosomal\\ dominant\\ disorder\\ that\\ is\\ often\\ associated\\ with\\ pulmonary\\ arteriovenous\\ malformations\\.\\ hht\\ is\\ a\\ rare\\ disorder\\ that\\ was\\ formerly\\ thought\\ to\\ only\\ be\\ associated\\ with\\ benign\\ manifestations\\.\\ \\ it\\ is\\ now\\ recognized\\ however\\ that\\ there\\ may\\ be\\ more\\ severe\\ complications\\ of\\ the\\ disease\\.\\ \\ some\\ of\\ the\\ signs\\ and\\ symptoms\\ include\\:\ \(0\)\
\-\ epistaxis\ \(16\)\
\-\ hemoptysis\ \(61\)\
\-\ dyspnea\ \(130\)\
\-\ clubbing\\ of\\ digits\ \(0\)\
\-\ mucocutaneous\\ telangiectasias\ \(1\)\
\-\ gastrointestinal\\ bleeding\ \(5\)\
\-\ bruits\\/murmurs\ \(0\)\
\-\ high\\ output\\ chf\ \(0\)\
\-\ the\\ diagnosis\\ of\\ hht\\ requires\\ certain\\ criteria\\ be\\ met\\.\\ \\ the\\ criteria\\ are\\ as\\ follows\\:\ \(0\)\
\-\ recurrent\\ episodes\\ of\\ spontaneous\\ epistaxis\ \(0\)\
\-\ mucocutaneous\\ telangiectasias\ \(1\)\
\-\ visceral\\ avm\\'s\ \(0\)\
\-\ first\\ degree\\ relative\\ affected\\ in\\ autosomal\\ dominant\\ interitance\\ pattern\ \(0\)\
\-\ meeting\\ 3\\ or\\ more\\ criteria\\ is\\ sufficient\\ for\\ a\\ definite\\ diagnosis\\ of\\ hht\\.\\ \\ meeting\\ 2\\ out\\ of\\ 4\\ is\\ inconclusive\\ and\\ leads\\ to\\ the\\ designation\\ of\\ a\\ possible\\ diagnosis\\.\\ \\ if\\ less\\ than\\ 2\\ out\\ of\\ 4\\ criteria\\ are\\ met\\ then\\ the\\ diagnosis\\ is\\ unlikely\\.\\ \\ for\\ this\\ patient\\,\\ he\\ definitely\\ has\\ recurrent\\ episodes\\ of\\ epistaxis\\ by\\ history\\.\\ \\ the\\ ct\\ findings\\ of\\ pulmonary\\ avm\\'s\\ satisfies\\ the\\ visceral\\ avm\\ criteria\\.\\ \\ while\\ no\\ mucosal\\ lesions\\ were\\ seen\\ he\\ did\\ have\\ several\\ cutaneous\\ telangiectasias\\.\\ \\ his\\ father\\ did\\ not\\ have\\ a\\ strong\\ history\\ of\\ hht\\ but\\ did\\ have\\ the\\ mucocutaneous\\ telangiectasias\\.\\ \\ given\\ that\\ hht\\ sometimes\\ shows\\ incomplete\\ penetrance\\,\\ the\\ father\\ may\\ have\\ had\\ a\\ milder\\ form\\.\\ \\ thus\\ this\\ patient\\ has\\ unequivically\\ met\\ 2\\ out\\ of\\ the\\ 4\\ criteria\\ and\\ may\\ have\\ met\\ 3\\ or\\ 4\\ out\\ of\\ 4\\ depending\\ upon\\ how\\ liberal\\ one\\ is\\ with\\ judging\\ his\\ situation\\.\ \(0\)\
\-\ specific\\ to\\ this\\ patient\\'s\\ presentation\\ is\\ the\\ pulmonary\\ ateriovenous\\ malformations\\.\\ \\ pulmonary\\ avm\\'s\\ are\\ a\\ rare\\ condition\\ and\\ have\\ relatively\\ few\\ causes\\.\\ \\ 50\\-70\\%\\ of\\ pulmonary\\ avm\\'s\\ are\\ caused\\ by\\ hht\\.\\ \\ the\\ other\\ causes\\ include\\ hepatopulmonary\\ syndrome\\(hepatic\\ cirrhosis\\)\\,\\ trauma\\,\\ and\\ metastatic\\ thyroid\\ cancer\\.\\ \\ the\\ radiographic\\ findings\\ in\\ hht\\ are\\ usually\\ related\\ to\\ arteriovenous\\ malformations\\.\\ \\ chest\\ x\\-rays\\ are\\ usually\\ abnormal\\ in\\ patients\\ with\\ pulmonary\\ avm\\'s\\.\\ \\ these\\ cxr\\'s\\ have\\ a\\ round\\ mass\\ with\\ linear\\ vasculature\\ markings\\ entering\\ and\\ leaving\\.\\ \\ the\\ cxr\\ however\\ is\\ not\\ specific\\ in\\ differentiating\\ the\\ lesion\\ from\\ other\\ causes\\ of\\ masses\\ in\\ the\\ lungs\\.\\ \\ the\\ ct\\ scan\\ with\\ contrast\\ can\\ further\\ delineate\\ the\\ mass\\ by\\ showing\\ that\\ it\\ has\\ the\\ same\\ consitency\\ as\\ the\\ blood\\ vessels\\.\\ \\ often\\ the\\ dilated\\ artery\\ feeding\\ and\\ dilated\\ vein\\ draining\\ the\\ avm\\ can\\ be\\ identified\\.\\ \\ angiography\\ may\\ not\\ be\\ needed\\ for\\ diagnosis\\ but\\ can\\ definitely\\ demonstrate\\ the\\ vascular\\ nature\\ of\\ the\\ lesion\\ and\\ is\\ often\\ performed\\ durning\\ therapuetic\\ interventions\\.\\ other\\ studies\\ include\\ contrast\\ echocardiography\\,\\ radionuclide\\ perfusion\\ lung\\ scan\\,\\ shung\\ fraction\\ measurement\\,\\ and\\ mri\\.\ \(0\)\
\-\ as\\ alluded\\ to\\ previously\\ hht\\ is\\ being\\ recognized\\ as\\ a\\ cause\\ of\\ more\\ serious\\ morbidity\\ and\\ mortality\\ than\\ previously\\ thought\\.\\ some\\ of\\ the\\ more\\ serious\\ complications\\ are\\ tia\\,\\ cva\\,\\ and\\ brain\\ abscess\\,\\ all\\ thought\\ to\\ result\\ from\\ clots\\ bypassing\\ the\\ pulmonary\\ capillary\\ bed\\.\\ \\ other\\ complications\\ include\\ seizures\\,\\ intracerebral\\ hemorrhage\\,\\ especially\\ if\\ associated\\ with\\ intracranial\\ avm\\,\\ hemoptysis\\,\\ high\\ output\\ chf\\ from\\ shunting\\ and\\ polycythemia\\.\\ this\\ patient\\ does\\ not\\ currently\\ exhibit\\ any\\ of\\ these\\ more\\ serious\\ complications\\ but\\ does\\ have\\ clubbing\\ of\\ the\\ digits\\ which\\ is\\ suggestive\\ of\\ chronic\\ hypoxia\\.\ \(0\)\
\-\ the\\ treatment\\ of\\ pulmonary\\ avm\\'s\\ in\\ hht\\ is\\ aimed\\ at\\ preventing\\ the\\ more\\ serious\\ complications\\ of\\ the\\ disease\\,\\ i\\.e\\.\\ the\\ neurological\\ and\\ cardiopulmonary\\ complications\\.\\ treatment\\ for\\ large\\ avm\\'s\\ greater\\ than\\ 2\\ cm\\ in\\ diameter\\ or\\ with\\ a\\ feeding\\ artery\\ greater\\ than\\ 3\\ mm\\ in\\ diameter\\ is\\ either\\ surgical\\ ligation\\ or\\ intravascular\\ embolization\\.\\ embolization\\ is\\ the\\ preferred\\ method\\ as\\ this\\ spares\\ the\\ normal\\ lung\\ tissue\\ that\\ may\\ be\\ removed\\ or\\ damaged\\ in\\ surgical\\ resection\\.\\ \\ embolization\\ also\\ has\\ the\\ benefit\\ of\\ being\\ less\\ invasive\\ and\\ angiography\\ done\\ at\\ that\\ time\\ may\\ detect\\ other\\ lesions\\ in\\ need\\ of\\ treatment\\.\\ \\ small\\ lesions\\ may\\ not\\ need\\ to\\ be\\ treated\\ and\\ it\\ is\\ worth\\ restating\\ that\\ the\\ treatment\\ of\\ the\\ pulmonary\\ avm\\'s\\ is\\ done\\ to\\ reduce\\ the\\ risk\\ of\\ serious\\ strokes\\,\\ brain\\ abscesses\\,\\ and\\ other\\ neurological\\ complicaiton\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ avm\\:\\ 0\\.3342718015351938\ \(0\)\
\-\ hht\\:\\ 0\\.3189901403686123\ \(0\)\
\-\ the\\:\\ 0\\.23630651447442216\ \(0\)\
\-\ telangiectasias\\:\\ 0\\.21749221808031977\ \(0\)\
\-\ pulmonary\\:\\ 0\\.19966685344177013\ \(0\)\
\-\ of\\:\\ 0\\.17751684375133314\ \(0\)\
\-\ criteria\\:\\ 0\\.14992348571735403\ \(0\)\
\-\ serious\\:\\ 0\\.1424193058763196\ \(0\)\
\-\ have\\:\\ 0\\.1384624239124487\ \(0\)\
\-\ is\\:\\ 0\\.1242087206436352\ \(0\)\
\-\ met\\:\\ 0\\.12050055379138727\ \(0\)\
\-\ and\\:\\ 0\\.11975497900530144\ \(0\)\
\-\ complications\\:\\ 0\\.11579108596172527\ \(0\)\
\-\ mucocutaneous\\:\\ 0\\.11551539363784714\ \(0\)\
\-\ other\\:\\ 0\\.10468339527919988\ \(0\)\
\-\ malformations\\:\\ 0\\.10168831556997607\ \(0\)\
\-\ that\\:\\ 0\\.09841261549558913\ \(0\)\
\-\ arteriovenous\\:\\ 0\\.09668162126391154\ \(0\)\
\-\ epistaxis\\:\\ 0\\.09418767872947173\ \(0\)\
\-\ may\\:\\ 0\\.08876095160440672\ \(0\)\
\-\ embolization\\:\\ 0\\.0878404414494163\ \(0\)\
\-\ in\\:\\ 0\\.08775620243776827\ \(0\)\
\-\ more\\:\\ 0\\.08301646963931995\ \(0\)\
\-\ clubbing\\:\\ 0\\.08258626963053957\ \(0\)\
\-\ father\\:\\ 0\\.08054351810412884\ \(0\)\
\-\ hereditary\\:\\ 0\\.0777133079495285\ \(0\)\
\-\ he\\:\\ 0\\.0746049405250561\ \(0\)\
\-\ did\\:\\ 0\\.07230247006984987\ \(0\)\
\-\ be\\:\\ 0\\.07155109984366993\ \(0\)\
\-\ meeting\\:\\ 0\\.06730464221810599\ \(0\)\
\-\ are\\:\\ 0\\.0669289226982108\ \(0\)\
\-\ out\\:\\ 0\\.06625047507671687\ \(0\)\
\-\ several\\:\\ 0\\.06612791593239643\ \(0\)\
\-\ hemorrhagic\\:\\ 0\\.06557093988946282\ \(0\)\
\-\ diagnosis\\:\\ 0\\.06531081798622619\ \(0\)\
\-\ thought\\:\\ 0\\.06526860766566957\ \(0\)\
\-\ definitely\\:\\ 0\\.06405600109743195\ \(0\)\
\-\ to\\:\\ 0\\.06299305341973188\ \(0\)\
\-\ lung\\:\\ 0\\.061311525711606495\ \(0\)\
\-\ for\\:\\ 0\\.06109715538073029\ \(0\)\
\-\ as\\:\\ 0\\.060736185711078285\ \(0\)\
\-\ cxr\\:\\ 0\\.060472511944645965\ \(0\)\
\-\ include\\:\\ 0\\.05996894041226351\ \(0\)\
\-\ bruits\\:\\ 0\\.05981924330162571\ \(0\)\
\-\ not\\:\\ 0\\.059684050651695505\ \(0\)\
\-\ output\\:\\ 0\\.059408265190021674\ \(0\)\
\-\ telangiectasia\\:\\ 0\\.059015558928222196\ \(0\)\
\-\ visceral\\:\\ 0\\.058639568728612\ \(0\)\
\-\ lesions\\:\\ 0\\.05788465505711794\ \(0\)\
\-\ has\\:\\ 0\\.05754723483729996\ \(0\)\
\-\ than\\:\\ 0\\.057134802540415044\ \(0\)\
\-\ causes\\:\\ 0\\.057119073369263335\ \(0\)\
\-\ lungs\\:\\ 0\\.05578767262883457\ \(0\)\
\-\ recognized\\:\\ 0\\.05556247544917581\ \(0\)\
\-\ chf\\:\\ 0\\.05530638690316754\ \(0\)\
\-\ digits\\:\\ 0\\.055057513087026375\ \(0\)\
\-\ with\\:\\ 0\\.054273666951525586\ \(0\)\
\-\ dilated\\:\\ 0\\.05414052225131423\ \(0\)\
\-\ associated\\:\\ 0\\.05312371817385031\ \(0\)\
\-\ disease\\:\\ 0\\.05288490748766079\ \(0\)\
\-\ was\\:\\ 0\\.05268930065590135\ \(0\)\
\-\ or\\:\\ 0\\.05259440110026298\ \(0\)\
\-\ hemoptysis\\:\\ 0\\.05215536485564984\ \(0\)\
\-\ autosomal\\:\\ 0\\.05198041980759018\ \(0\)\
\-\ 73\\:\\ 0\\.05180887196635233\ \(0\)\
\-\ it\\:\\ 0\\.05159282713609514\ \(0\)\
\-\ vasculature\\:\\ 0\\.04956979381426558\ \(0\)\
\-\ often\\:\\ 0\\.04932394361716915\ \(0\)\
\-\ murmurs\\:\\ 0\\.04834081063195577\ \(0\)\
\-\ treatment\\:\\ 0\\.04801147141528539\ \(0\)\
\-\ feeding\\:\\ 0\\.047262102143402415\ \(0\)\
\-\ dominant\\:\\ 0\\.04716113605894206\ \(0\)\
\-\ angiography\\:\\ 0\\.04657843459854141\ \(0\)\
\-\ need\\:\\ 0\\.04639243959753239\ \(0\)\
\-\ episodes\\:\\ 0\\.04603180029011003\ \(0\)\
\-\ his\\:\\ 0\\.04584488223730072\ \(0\)\
\-\ scan\\:\\ 0\\.04484804746026884\ \(0\)\
\-\ this\\:\\ 0\\.0432914352835922\ \(0\)\
\-\ by\\:\\ 0\\.042801142561362276\ \(0\)\
\-\ disorder\\:\\ 0\\.042628224178019994\ \(0\)\
\-\ neurological\\:\\ 0\\.04139611956250705\ \(0\)\
\-\ patient\\:\\ 0\\.04097727787597069\ \(0\)\
\-\ intracranial\\:\\ 0\\.040549356882678494\ \(0\)\
\-\ diameter\\:\\ 0\\.04050198713792024\ \(0\)\
\-\ previously\\:\\ 0\\.04045487003300161\ \(0\)\
\-\ recurrent\\:\\ 0\\.040408002887374846\ \(0\)\
\-\ syndome\\:\\ 0\\.040296159033408524\ \(0\)\
\-\ interitance\\:\\ 0\\.040296159033408524\ \(0\)\
\-\ penetrance\\:\\ 0\\.040296159033408524\ \(0\)\
\-\ unequivically\\:\\ 0\\.040296159033408524\ \(0\)\
\-\ liberal\\:\\ 0\\.040296159033408524\ \(0\)\
\-\ judging\\:\\ 0\\.040296159033408524\ \(0\)\
\-\ hepatopulmonary\\:\\ 0\\.040296159033408524\ \(0\)\
\-\ consitency\\:\\ 0\\.040296159033408524\ \(0\)\
\-\ durning\\:\\ 0\\.040296159033408524\ \(0\)\
\-\ shung\\:\\ 0\\.040296159033408524\ \(0\)\
\-\ bypassing\\:\\ 0\\.040296159033408524\ \(0\)\
\-\ restating\\:\\ 0\\.040296159033408524\ \(0\)\
\-\ complicaiton\\:\\ 0\\.040296159033408524\ \(0\)\
\-\ done\\:\\ 0\\.04008671525406581\ \(0\)\
\-\ can\\:\\ 0\\.03966842224169926\ \(0\)\
\-\ small\\:\\ 0\\.038993032547926854\ \(0\)\
\-\ were\\:\\ 0\\.03896562477322002\ \(0\)\
\-\ satisfies\\:\\ 0\\.03850513121261571\ \(0\)\
\-\ therapuetic\\:\\ 0\\.03850513121261571\ \(0\)\
\-\ alluded\\:\\ 0\\.03850513121261571\ \(0\)\
\-\ ct\\:\\ 0\\.0383715764793151\ \(0\)\
\-\ specific\\:\\ 0\\.03818778159672969\ \(0\)\
\-\ rare\\:\\ 0\\.038043542699127186\ \(0\)\
\-\ had\\:\\ 0\\.03766284228060668\ \(0\)\
\-\ but\\:\\ 0\\.03738048972784665\ \(0\)\
\-\ spider\\:\\ 0\\.03723437675063862\ \(0\)\
\-\ fingernails\\:\\ 0\\.03723437675063862\ \(0\)\
\-\ ateriovenous\\:\\ 0\\.03723437675063862\ \(0\)\
\-\ spares\\:\\ 0\\.03723437675063862\ \(0\)\
\-\ greater\\:\\ 0\\.03712706031853526\ \(0\)\
\-\ perioral\\:\\ 0\\.036248703013386625\ \(0\)\
\-\ nosebleeds\\:\\ 0\\.036248703013386625\ \(0\)\
\-\ designation\\:\\ 0\\.036248703013386625\ \(0\)\
\-\ polycythemia\\:\\ 0\\.036248703013386625\ \(0\)\
\-\ lesion\\:\\ 0\\.03624061010551768\ \(0\)\
\-\ also\\:\\ 0\\.035556431763815226\ \(0\)\
\-\ being\\:\\ 0\\.03511710636060611\ \(0\)\
\-\ does\\:\\ 0\\.034839032478743884\ \(0\)\
\-\ bluish\\:\\ 0\\.03476243175437557\ \(0\)\
\-\ formerly\\:\\ 0\\.03476243175437557\ \(0\)\
\-\ which\\:\\ 0\\.0343725518417427\ \(0\)\
\-\ less\\:\\ 0\\.03428443832183504\ \(0\)\
\-\ possible\\:\\ 0\\.03414531046645277\ \(0\)\
\-\ po2\\:\\ 0\\.033652321109052995\ \(0\)\
\-\ plans\\:\\ 0\\.033652321109052995\ \(0\)\
\-\ fhx\\:\\ 0\\.033652321109052995\ \(0\)\
\-\ milder\\:\\ 0\\.033652321109052995\ \(0\)\
\-\ aimed\\:\\ 0\\.033652321109052995\ \(0\)\
\-\ worth\\:\\ 0\\.033652321109052995\ \(0\)\
\-\ back\\:\\ 0\\.03360972611097076\ \(0\)\
\-\ further\\:\\ 0\\.032823003860342044\ \(0\)\
\-\ no\\:\\ 0\\.03277565623110569\ \(0\)\
\-\ strokes\\:\\ 0\\.032765914877780744\ \(0\)\
\-\ any\\:\\ 0\\.032569179393339316\ \(0\)\
\-\ inconclusive\\:\\ 0\\.032028000548715976\ \(0\)\
\-\ clots\\:\\ 0\\.032028000548715976\ \(0\)\
\-\ usually\\:\\ 0\\.0317254181211241\ \(0\)\
\-\ some\\:\\ 0\\.031707941485887015\ \(0\)\
\-\ situation\\:\\ 0\\.03170064947160567\ \(0\)\
\-\ brain\\:\\ 0\\.031416009353650236\ \(0\)\
\-\ damaged\\:\\ 0\\.031395892909823905\ \(0\)\
\-\ artery\\:\\ 0\\.03129855073143957\ \(0\)\
\-\ genetics\\:\\ 0\\.031110812185098813\ \(0\)\
\-\ intracerebral\\:\\ 0\\.031110812185098813\ \(0\)\
\-\ delineate\\:\\ 0\\.030843020007357808\ \(0\)\
\-\ radionuclide\\:\\ 0\\.030843020007357808\ \(0\)\
\-\ tia\\:\\ 0\\.030351712117026045\ \(0\)\
\-\ abnormal\\:\\ 0\\.030276544285526296\ \(0\)\
\-\ from\\:\\ 0\\.030022040117553918\ \(0\)\
\-\ differentiating\\:\\ 0\\.029909621650812856\ \(0\)\
\-\ fraction\\:\\ 0\\.029909621650812856\ \(0\)\
\-\ preventing\\:\\ 0\\.029909621650812856\ \(0\)\
\-\ however\\:\\ 0\\.029827852408083295\ \(0\)\
\-\ entering\\:\\ 0\\.029704132595010837\ \(0\)\
\-\ cva\\:\\ 0\\.029704132595010837\ \(0\)\
\-\ intravascular\\:\\ 0\\.029704132595010837\ \(0\)\
\-\ shows\\:\\ 0\\.029577410673536864\ \(0\)\
\-\ leaving\\:\\ 0\\.029507779464111098\ \(0\)\
\-\ cardiopulmonary\\:\\ 0\\.029507779464111098\ \(0\)\
\-\ interventions\\:\\ 0\\.029319784364306\ \(0\)\
\-\ if\\:\\ 0\\.029280653616968653\ \(0\)\
\-\ exhibit\\:\\ 0\\.029139464710594823\ \(0\)\
\-\ ligation\\:\\ 0\\.029139464710594823\ \(0\)\
\-\ sizes\\:\\ 0\\.02896621826594607\ \(0\)\
\-\ measurement\\:\\ 0\\.02896621826594607\ \(0\)\
\-\ one\\:\\ 0\\.02885341081301736\ \(0\)\
\-\ high\\:\\ 0\\.028641124392594086\ \(0\)\
\-\ certain\\:\\ 0\\.02848386117526392\ \(0\)\
\-\ these\\:\\ 0\\.02845795743958429\ \(0\)\
\-\ echocardiography\\:\\ 0\\.028334110627054005\ \(0\)\
\-\ shunting\\:\\ 0\\.028334110627054005\ \(0\)\
\-\ sufficient\\:\\ 0\\.027781237724587904\ \(0\)\
\-\ hypoxia\\:\\ 0\\.027781237724587904\ \(0\)\
\-\ method\\:\\ 0\\.027781237724587904\ \(0\)\
\-\ metastatic\\:\\ 0\\.02763904806459908\ \(0\)\
\-\ symptoms\\:\\ 0\\.02757320103008828\ \(0\)\
\-\ consulted\\:\\ 0\\.02728992983425614\ \(0\)\
\-\ detect\\:\\ 0\\.027175190445153256\ \(0\)\
\-\ morbidity\\:\\ 0\\.027063356165076914\ \(0\)\
\-\ fingers\\:\\ 0\\.026954283509420397\ \(0\)\
\-\ interventional\\:\\ 0\\.02684783936804295\ \(0\)\
\-\ preferred\\:\\ 0\\.026743900028612766\ \(0\)\
\-\ benefit\\:\\ 0\\.026743900028612766\ \(0\)\
\-\ noted\\:\\ 0\\.026719269687486086\ \(0\)\
\-\ how\\:\\ 0\\.026642350312240933\ \(0\)\
\-\ wheezes\\:\\ 0\\.02654308280626119\ \(0\)\
\-\ cirrhosis\\:\\ 0\\.02654308280626119\ \(0\)\
\-\ varying\\:\\ 0\\.026445997181341194\ \(0\)\
\-\ capillary\\:\\ 0\\.026445997181341194\ \(0\)\
\-\ strong\\:\\ 0\\.026258002081536093\ \(0\)\
\-\ cyanosis\\:\\ 0\\.026166922192572717\ \(0\)\
\-\ saturation\\:\\ 0\\.026166922192572717\ \(0\)\
\-\ cutaneous\\:\\ 0\\.026166922192572717\ \(0\)\
\-\ bed\\:\\ 0\\.026166922192572717\ \(0\)\
\-\ visit\\:\\ 0\\.02599020990379509\ \(0\)\
\-\ oxygen\\:\\ 0\\.025904435983176165\ \(0\)\
\-\ manifestations\\:\\ 0\\.02582029595128149\ \(0\)\
\-\ reduce\\:\\ 0\\.025656676574988938\ \(0\)\
\-\ abscesses\\:\\ 0\\.02557708490606586\ \(0\)\
\-\ leads\\:\\ 0\\.025422078892494017\ \(0\)\
\-\ supply\\:\\ 0\\.025346569051782824\ \(0\)\
\-\ future\\:\\ 0\\.0252723283442841\ \(0\)\
\-\ markings\\:\\ 0\\.0252723283442841\ \(0\)\
\-\ perfusion\\:\\ 0\\.0252723283442841\ \(0\)\
\-\ findings\\:\\ 0\\.024871874245509823\ \(0\)\
\-\ genetic\\:\\ 0\\.02485132249144812\ \(0\)\
\-\ definite\\:\\ 0\\.02478489690713279\ \(0\)\
\-\ mortality\\:\\ 0\\.02478489690713279\ \(0\)\
\-\ incomplete\\:\\ 0\\.024719455441818\ \(0\)\
\-\ collections\\:\\ 0\\.024654969360548378\ \(0\)\
\-\ breathing\\:\\ 0\\.024654969360548378\ \(0\)\
\-\ follows\\:\\ 0\\.024654969360548378\ \(0\)\
\-\ surgical\\:\\ 0\\.024493535487937375\ \(0\)\
\-\ contrast\\:\\ 0\\.024485823190432073\ \(0\)\
\-\ requires\\:\\ 0\\.024406046148345555\ \(0\)\
\-\ draining\\:\\ 0\\.024406046148345555\ \(0\)\
\-\ mucosa\\:\\ 0\\.024286654607032106\ \(0\)\
\-\ opacities\\:\\ 0\\.02405713710694377\ \(0\)\
\-\ determined\\:\\ 0\\.02400157388230701\ \(0\)\
\-\ depending\\:\\ 0\\.02400157388230701\ \(0\)\
\-\ always\\:\\ 0\\.023786057085273045\ \(0\)\
\-\ workup\\:\\ 0\\.023733781704566005\ \(0\)\
\-\ mucosal\\:\\ 0\\.023733781704566005\ \(0\)\
\-\ possibly\\:\\ 0\\.023682117745842862\ \(0\)\
\-\ observation\\:\\ 0\\.023631051071701208\ \(0\)\
\-\ sometimes\\:\\ 0\\.02358056802947103\ \(0\)\
\-\ except\\:\\ 0\\.02348130052349129\ \(0\)\
\-\ thus\\:\\ 0\\.023150445108144322\ \(0\)\
\-\ entire\\:\\ 0\\.022928427621025187\ \(0\)\
\-\ invasive\\:\\ 0\\.022928427621025187\ \(0\)\
\-\ on\\:\\ 0\\.02283015945063007\ \(0\)\
\-\ times\\:\\ 0\\.02267594643995047\ \(0\)\
\-\ granulomatous\\:\\ 0\\.022398541161319296\ \(0\)\
\-\ relative\\:\\ 0\\.022322380341590543\ \(0\)\
\-\ unlikely\\:\\ 0\\.022322380341590543\ \(0\)\
\-\ vitals\\:\\ 0\\.022247510445554952\ \(0\)\
\-\ nature\\:\\ 0\\.022247510445554952\ \(0\)\
\-\ states\\:\\ 0\\.022137532529496528\ \(0\)\
\-\ degree\\:\\ 0\\.02203022640780302\ \(0\)\
\-\ form\\:\\ 0\\.02203022640780302\ \(0\)\
\-\ spontaneous\\:\\ 0\\.021925465336789105\ \(0\)\
\-\ regular\\:\\ 0\\.021756202555223186\ \(0\)\
\-\ showing\\:\\ 0\\.021756202555223186\ \(0\)\
\-\ evaluated\\:\\ 0\\.021529628886043962\ \(0\)\
\-\ mother\\:\\ 0\\.021529628886043962\ \(0\)\
\-\ removed\\:\\ 0\\.02140519197797338\ \(0\)\
\-\ few\\:\\ 0\\.021374622872472118\ \(0\)\
\-\ difficulty\\:\\ 0\\.0211955219297952\ \(0\)\
\-\ either\\:\\ 0\\.02083071894388059\ \(0\)\
\-\ needed\\:\\ 0\\.020803866471426225\ \(0\)\
\-\ arterial\\:\\ 0\\.020750646332269286\ \(0\)\
\-\ affected\\:\\ 0\\.02072427480250314\ \(0\)\
\-\ admitted\\:\\ 0\\.02064609190990061\ \(0\)\
\-\ round\\:\\ 0\\.02064609190990061\ \(0\)\
\-\ bleeding\\:\\ 0\\.020594728329819293\ \(0\)\
\-\ normal\\:\\ 0\\.020575874729262426\ \(0\)\
\-\ seizures\\:\\ 0\\.020569268788931297\ \(0\)\
\-\ near\\:\\ 0\\.020518785746701126\ \(0\)\
\-\ relatively\\:\\ 0\\.020518785746701126\ \(0\)\
\-\ suggestive\\:\\ 0\\.020518785746701126\ \(0\)\
\-\ denies\\:\\ 0\\.020322432615801383\ \(0\)\
\-\ linear\\:\\ 0\\.02029849099558786\ \(0\)\
\-\ caused\\:\\ 0\\.020204001443687423\ \(0\)\
\-\ radiology\\:\\ 0\\.020180691531464342\ \(0\)\
\-\ drainage\\:\\ 0\\.020180691531464342\ \(0\)\
\-\ oral\\:\\ 0\\.020180691531464342\ \(0\)\
\-\ condition\\:\\ 0\\.020134437515996285\ \(0\)\
\-\ hepatic\\:\\ 0\\.020065952142361454\ \(0\)\
\-\ respiratory\\:\\ 0\\.020043357627032906\ \(0\)\
\-\ nodules\\:\\ 0\\.02002087809701279\ \(0\)\
\-\ same\\:\\ 0\\.019932086803570073\ \(0\)\
\-\ especially\\:\\ 0\\.019932086803570073\ \(0\)\
\-\ upon\\:\\ 0\\.019823550185547323\ \(0\)\
\-\ thyroid\\:\\ 0\\.019802159256985665\ \(0\)\
\-\ presenting\\:\\ 0\\.019738601065251153\ \(0\)\
\-\ vessels\\:\\ 0\\.01955323604478284\ \(0\)\
\-\ routine\\:\\ 0\\.019513079239895353\ \(0\)\
\-\ made\\:\\ 0\\.019433844503469393\ \(0\)\
\-\ currently\\:\\ 0\\.01935600604676049\ \(0\)\
\-\ an\\:\\ 0\\.019270817156206238\ \(0\)\
\-\ history\\:\\ 0\\.019253745776534194\ \(0\)\
\-\ mass\\:\\ 0\\.019249483081044363\ \(0\)\
\-\ related\\:\\ 0\\.019148763778744297\ \(0\)\
\-\ at\\:\\ 0\\.019034768558235163\ \(0\)\
\-\ 13\\:\\ 0\\.019003923979362156\ \(0\)\
\-\ result\\:\\ 0\\.0188636830540192\ \(0\)\
\-\ pattern\\:\\ 0\\.018812219736576808\ \(0\)\
\-\ like\\:\\ 0\\.01872775792590831\ \(0\)\
\-\ radiographic\\:\\ 0\\.018694420272453282\ \(0\)\
\-\ studies\\:\\ 0\\.01848365062054643\ \(0\)\
\-\ clear\\:\\ 0\\.018267379967701163\ \(0\)\
\-\ since\\:\\ 0\\.018252329806240093\ \(0\)\
\-\ congenital\\:\\ 0\\.018104582985946433\ \(0\)\
\-\ vein\\:\\ 0\\.018061205700059466\ \(0\)\
\-\ mm\\:\\ 0\\.01803252236475451\ \(0\)\
\-\ risk\\:\\ 0\\.01800402408451366\ \(0\)\
\-\ venous\\:\\ 0\\.01798984359684355\ \(0\)\
\-\ identified\\:\\ 0\\.017864227033774462\ \(0\)\
\-\ then\\:\\ 0\\.017836790808205428\ \(0\)\
\-\ obtained\\:\\ 0\\.01782313633638775\ \(0\)\
\-\ signs\\:\\ 0\\.017610217139026198\ \(0\)\
\-\ labs\\:\\ 0\\.017457003463931222\ \(0\)\
\-\ presentation\\:\\ 0\\.017345482917873665\ \(0\)\
\-\ given\\:\\ 0\\.017333263772832435\ \(0\)\
\-\ benign\\:\\ 0\\.01730892642137331\ \(0\)\
\-\ now\\:\\ 0\\.017296807845553753\ \(0\)\
\-\ cause\\:\\ 0\\.017165652733730902\ \(0\)\
\-\ masses\\:\\ 0\\.01715392040780147\ \(0\)\
\-\ areas\\:\\ 0\\.01710730025879136\ \(0\)\
\-\ three\\:\\ 0\\.01691447707006354\ \(0\)\
\-\ hemorrhage\\:\\ 0\\.016870304520800173\ \(0\)\
\-\ bilaterally\\:\\ 0\\.01680486305548538\ \(0\)\
\-\ showed\\:\\ 0\\.01678326292385869\ \(0\)\
\-\ cancer\\:\\ 0\\.01678326292385869\ \(0\)\
\-\ vascular\\:\\ 0\\.01663494910297178\ \(0\)\
\-\ known\\:\\ 0\\.016313555165153617\ \(0\)\
\-\ while\\:\\ 0\\.016284589696669658\ \(0\)\
\-\ abscess\\:\\ 0\\.016179978996478907\ \(0\)\
\-\ resection\\:\\ 0\\.01615187359021508\ \(0\)\
\-\ show\\:\\ 0\\.015995901607011007\ \(0\)\
\-\ severe\\:\\ 0\\.015951056367863505\ \(0\)\
\-\ age\\:\\ 0\\.015819189318233385\ \(0\)\
\-\ enhancing\\:\\ 0\\.01578467962617891\ \(0\)\
\-\ only\\:\\ 0\\.015741918226256577\ \(0\)\
\-\ treated\\:\\ 0\\.01569114504522925\ \(0\)\
\-\ abdomen\\:\\ 0\\.015374624912938088\ \(0\)\
\-\ month\\:\\ 0\\.015327881427901624\ \(0\)\
\-\ syndrome\\:\\ 0\\.015190547523470191\ \(0\)\
\-\ likely\\:\\ 0\\.015057354977021232\ \(0\)\
\-\ head\\:\\ 0\\.015028294226704727\ \(0\)\
\-\ all\\:\\ 0\\.014999423417289562\ \(0\)\
\-\ chronic\\:\\ 0\\.014956467959340258\ \(0\)\
\-\ time\\:\\ 0\\.014935145867501894\ \(0\)\
\-\ performed\\:\\ 0\\.014906875575065643\ \(0\)\
\-\ been\\:\\ 0\\.014680301905886414\ \(0\)\
\-\ trauma\\:\\ 0\\.014633699323196591\ \(0\)\
\-\ blood\\:\\ 0\\.014633699323196591\ \(0\)\
\-\ cm\\:\\ 0\\.014471163764279486\ \(0\)\
\-\ patients\\:\\ 0\\.014174926430048055\ \(0\)\
\-\ both\\:\\ 0\\.014051318657243283\ \(0\)\
\-\ consistent\\:\\ 0\\.013662619201643203\ \(0\)\
\-\ upper\\:\\ 0\\.013465110668546078\ \(0\)\
\-\ chest\\:\\ 0\\.013300474788252806\ \(0\)\
\-\ tissue\\:\\ 0\\.013217998248355978\ \(0\)\
\-\ demonstrate\\:\\ 0\\.013099439920703206\ \(0\)\
\-\ mri\\:\\ 0\\.012934119324241105\ \(0\)\
\-\ present\\:\\ 0\\.012929614256930016\ \(0\)\
\-\ large\\:\\ 0\\.012625157890066015\ \(0\)\
\-\ seen\\:\\ 0\\.011862741010997945\ \(0\)\
\-\ male\\:\\ 0\\.011218860395745385\ \(0\)\
\-\ there\\:\\ 0\\.010025974959566468\ \(0\)\
\-\ left\\:\\ 0\\.008595389295798768\ \(0\)\
\-\ right\\:\\ 0\\.00835398707854509\ \(0\)\
\-\ year\\:\\ 0\\.007765348548601467\ \(0\)\
\-\ old\\:\\ 0\\.007457422648765507\ \(0\)\
